Nepafenac

Nepafenac
Clinical data
Trade names Nevanac
AHFS/Drugs.com Monograph
MedlinePlus a606007
Pregnancy
category
  • US: C (Risk not ruled out)
Routes of
administration
Ophthalmic
ATC code S01BC10 (WHO)
Legal status
Legal status
Identifiers
PubChem (CID) 151075
IUPHAR/BPS 7564
DrugBank DB06802 YesY
ChemSpider 133160 YesY
UNII 0J9L7J6V8C YesY
KEGG D05143 YesY
ChEBI CHEBI:75922 N
ChEMBL CHEMBL1021 YesY
ECHA InfoCard 100.207.414
Chemical and physical data
Formula C15H14N2O2
Molar mass 254.28 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Nepafenac is a non-steroidal anti-inflammatory drug (NSAID), usually sold as a prescription eye drop 0.1% solution. Nepafenac is manufactured by Alcon and sold under the trade name Nevanac. It is used to treat pain and inflammation associated with cataract surgery.[1]

The usual dose is one drop, thrice a day, in each affected eye beginning one day prior to cataract surgery, continued on the day of surgery and through the first two weeks of the postoperative period.[1]

Nepafenac is a prodrug of amfenac, an inhibitor of COX-1 and COX-2 activity.[2][3] Its side effects may include decreased visual acuity, a feeling that something is in the eye, increased eye pressure or a sticky sensation, as well as other effects.[1]

Brand names of Nepafenac include Ilevro and Nevanac.

References


This article is issued from Wikipedia - version of the 9/7/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.